
FDA Watch: How Could the Change in US Government Affect IVDs and Labs?
Experts say new leadership could impact the cost and availability of IVDs as well as patients’ ability to afford lab testing
Experts say new leadership could impact the cost and availability of IVDs as well as patients’ ability to afford lab testing
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Our event equips diagnostic medicine professionals with innovative strategies to advance their practice, enhance patient care, and drive the future of the field
Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.
The grants, which include $3 million from the NIH and $1 million from the NSF, will help the company develop point-of-care tests